Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Benefits of anticoagulation decrease with age in AFib patients

The net clinical benefit of anticoagulants like warfarin and apixaban slows over time in patients with atrial fibrillation, according to a Circulation: Cardiovascular Quality and Outcomes study, diminishing as people age and face competing risks of death.

Thumbnail

FDA warns of biotin interference in diagnostic troponin tests

The FDA issued a safety communication Nov. 5 reminding the public, healthcare providers and lab workers that the common supplement vitamin B7, or biotin, can interfere with certain diagnostic tests, including troponin tests that can be integral to a heart attack diagnosis.

Risk of bleeding, hemorrhagic stroke notably higher in women than men after PCI

Women face a greater risk of bleeding and hemorrhagic stroke after PCI than men, according to a new subgroup analysis of the GLOBAL LEADERS trial.

Thumbnail

West Virginia achieves 1st-ever heart transplant

A 61-year-old patient at the West Virginia University Heart and Vascular Institute is the first in the state to receive a successful heart transplant, WVU reported Nov. 10.

Thumbnail

E-cigs could be more harmful to CV health than traditional cigarettes

A study out of the Smidt Heart Institute at Cedars-Sinai Medical Center suggests e-cigarettes—the culprit behind a vaping epidemic that’s injured more than 2,000 and claimed the lives of at least 39—could be more harmful to CV health than traditional cigarettes.

Thumbnail

AFib patients most likely to discontinue dabigatran during first 6 months of treatment

Nearly three-quarters of atrial fibrillation patients taking dabigatran remain adherent to the medication two years after filling their first prescription, while just over 25% discontinue the drug for various reasons, according to an analysis published in the American Journal of Cardiology.

Thumbnail

1st major study of hypertrophic cardiomyopathy offers clues about the elusive disease

Results from the world’s largest comprehensive study of hypertrophic cardiomyopathy patients are in—and they’re providing cardiologists with a wealth of previously unknown information about the disease.

Thumbnail

Long-term survival poor in patients with moderate, severe AS

Both severe and moderate aortic stenosis, when left untreated, were associated with poor long-term survival in a large-scale study of Australian heart patients.